HUMAN HEART VALVE CRYOVALVE SG
A Heart Valve Related Image
(Not Necessarily related to the device)Description:
HUMAN HEART VALVE CRYOVALVE SG by CRYOLIFE INC.
The HUMAN HEART VALVE CRYOVALVE SG, produced by CRYOLIFE INC., is an advanced medical device innovatively designed to replace a patient's damaged or diseased heart valves. As specialists in the field of cardiovascular surgery, CRYOLIFE INC. continuously brings forward industry-leading solutions and this heart valve is no exception.
This device's primary use is in heart valve surgeries wherein the patient's native valve is dysfunctional or disease-stricken. The CryoValve SG is a human heart valve preserved by CryoLife's SynerGraft technology, which aims to offer a valve replacement closely similar to the patient's own valve, both structurally and functionally.
The benefits of the HUMAN HEART VALVE CRYOVALVE SG are manifold. By replacing the damaged heart valve with CryoValve, not only does it improve the patient's quality of life by aiding in restoring normal blood flow, but it also eliminates the need for lifelong anticoagulant therapy that is usually essential with mechanical prosthetic valves.
The HUMAN HEART VALVE CRYOVALVE SG implements CRYOLIFE INC.'s proprietary SynerGraft technology, providing a natural heart valve free of any cellular components that could cause an immune response. This feature helps in reducing the risks associated with post-surgical complications and taking a giant leap towards better patient recovery.
The CryoValve SG works by effectively taking over the normal function of a native heart valve. During a surgical procedure, the dysfunctional valve is removed, and the CryoValve is sutured into place. Once successfully implanted, the CryoValve seamlessly mimics the physiological function of opening and closing to control the flow of blood through the heart, thereby restoring the healthy functionality of the heart.
In summary, the HUMAN HEART VALVE CRYOVALVE SG is an innovative, cutting-edge medical device that stands out for its physiological similarity to a natural heart valve and its significant contribution to enhanced patient recovery. Backed by CRYOLIFE INC.'s trusted expertise, this product ensures continued advancements in cardiovascular medicine.
Primary Use:
The primary medical use of the device 'Human Heart Valve CryoValve SG' in the category 'Cardiovascular Surgical Devices' is for the replacement of dysfunctional or diseased heart valves. Specifically, it is designed for cardiac valve replacement surgeries like aortic or mitral valve replacements. This device includes cryopreserved, de-cellularized human heart valves which are utilized to facilitate the restoration of efficient blood flow in patients suffering from valvular heart diseases like stenosis or regurgitation
How It Works:
The CryoValve SG is a specific brand of Human Heart Valve prosthesis, manufactured by CryoLife, that belongs to the broader category of cardiovascular surgical devices. It is used in surgical procedures where a patient's native heart valve is diseased or malfunctioning and needs to be replaced. The CryoValve SG is unique in that it utilizes a process known as cryopreservation, where a donated human heart valve is preserved at low temperatures until it needs to be used. This differs from mechanical or other bio-prosthetic valves as it uses a real human heart valve, providing a more natural option for patients and doctors. The replacement process begins with a surgery known as a valvoplasty. During this procedure, the surgeon will remove the patient's faulty heart valve and replace it with a CryoValve SG. These heart valves can replace either the pulmonary or aortic valves, depending on the patient's needs. Once the replacement valve is surgically installed, it facilitates blood flow in the same way a native valve would. The valve consists of flaps called leaflets; when the heart contracts, this action forces the leaflets open allowing blood to pass through. When the heart relaxes, the leaflets close, preventing the blood from flowing backward. One of the advantages of CryoValve SG is its preparation process: it undergoes a unique patented SynerGraft technology that removes donor cells and cellular remnants from the valve, potentially reducing the patient's immune response to the replacement valve. This reduction in immune response often results in longer valve life and eliminates the need for aggressive anticoagulation therapy commonly associated with mechanical valve replacements. Overall, CryoValve SG serves the crucial purpose of assuring efficient, unobstructed blood flow within a patient's heart, thereby greatly improving their quality of life and potentially extending their lifespan. As with any surgical procedure, risks are associated, and therefore a thorough evaluation must be undertaken by the healthcare team to determine if this is the suitable treatment option for the patient. As cardiologists and medical device experts, we place utmost emphasis on maximizing therapeutic utility and patient safety while adhering to stringent standards of clinical ethics and scientific integrity.Manufacturer:
CRYOLIFE INC.
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.